Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pulmonx (LUNG) Income from Continuing Operations (2019 - 2025)

Pulmonx (LUNG) has disclosed Income from Continuing Operations for 7 consecutive years, with 13952000.0 as the latest value for Q3 2025.

  • Quarterly Income from Continuing Operations rose 1.41% to 13952000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 56675000.0 through Sep 2025, up 0.81% year-over-year, with the annual reading at 56394000.0 for FY2024, 7.31% up from the prior year.
  • Income from Continuing Operations for Q3 2025 was 13952000.0 at Pulmonx, up from 15173000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 10181000.0 in Q3 2021, with the low at 16155000.0 in Q2 2023.
  • Average Income from Continuing Operations over 5 years is 14120421.05, with a median of 14172000.0 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations plummeted 163.76% in 2021, then grew 13.18% in 2024.
  • Over 5 years, Income from Continuing Operations stood at 13006000.0 in 2021, then decreased by 9.82% to 14283000.0 in 2022, then rose by 2.6% to 13911000.0 in 2023, then increased by 5.56% to 13137000.0 in 2024, then decreased by 6.2% to 13952000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 13952000.0, 15173000.0, and 14413000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.